EMD emyria limited
Add to My Watchlist 5.13% ! 4.1¢

great newsemd first company received the approval. will be first...

  1. happy668
    577 Posts.
    lightbulb Created with Sketch. 41
    clock Created with Sketch.
    08/06/23
    14:58
    Post #: 68198272
    great news

    emd first company received the approval.
    will be first company offer mdma treatment in July. it is a massive market opportunity. I think patients already on the waiting list. 3 weeks away from July

    it is really going to save many people lives.
    EMD Price at posting: 13.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 8  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Watch the Latest Video Interviews here
right-arrow Created with Sketch.
NEWS Renascor produces graphite concentrate at Siviour, right on time to meet ex-China demand
right-arrow Created with Sketch.
NEWS Exclusive Pre-IPO & ASX-Listed Investment Opportunities
right-arrow Created with Sketch.
NEWS Capricorn Metals, capped at $4B, picking up Warriedar – but holders unhappy
right-arrow Created with Sketch.
NEWS What is going on here? Watch out for DroneShield, Pure Hydrogen, and Nel ASA
right-arrow Created with Sketch.
NEWS As Albo spruiks hydrogen in China, FMG is exiting the game
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
4.1¢ 		Change
0.002(5.13%) 		Mkt cap ! $25.06M
Open High Low Value Volume
3.8¢ 4.1¢ 3.8¢ $61.46K 1.550M

Buyers (Bids)

No. Vol. Price($)
1 1 4.1¢
 

Sellers (Offers)

Price($) Vol. No.
4.2¢ 90000 3
View Market Depth
Last trade - 15.50pm 25/07/2025 (20 minute delay) ?
EMD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.